---
title: "Henan Jinyuan Hydrogenated Chemicals Swings to Shareholder Loss on Weaker 2025 Revenue"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280181071.md"
description: "Henan Jinyuan Hydrogenated Chemicals Co., Ltd. reported a significant decline in 2025 revenue, falling to RMB2.60 billion from RMB3.10 billion the previous year. The company experienced a net loss of RMB34.3 million attributable to shareholders, despite reduced costs. This downturn raises concerns about the sustainability of growth in its hydrogenated chemicals segment. Analysts currently rate the stock as a Hold with a price target of HK$0.50, reflecting cautious sentiment amid deteriorating earnings quality and profitability."
datetime: "2026-03-23T14:13:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280181071.md)
  - [en](https://longbridge.com/en/news/280181071.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280181071.md)
---

# Henan Jinyuan Hydrogenated Chemicals Swings to Shareholder Loss on Weaker 2025 Revenue

### Claim 30% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

An announcement from Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H ( (HK:2502) ) is now available.

Henan Jinyuan Hydrogenated Chemicals reported 2025 revenue of RMB2.60 billion, down from RMB3.10 billion a year earlier, as gross profit narrowed sharply and joint-venture performance turned negative. The group swung to a net loss attributable to shareholders of RMB34.3 million, despite lower selling, administrative and finance costs, while non-controlling interests remained profitable, underscoring pressure on the core business and margins.

Overall, the company’s total comprehensive loss attributable to shareholders reached RMB34.2 million, compared with income in 2024, highlighting a deterioration in earnings quality and profitability. The results suggest a more challenging operating environment for its hydrogenated chemicals segment and may raise concerns among investors about the sustainability of growth and returns if revenue softness and margin compression persist.

The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.

**More about Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H**

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. is a People’s Republic of China-based joint stock company listed in Hong Kong, operating in the chemicals industry. The group focuses on hydrogenated chemical products and related downstream applications, serving industrial customers through its production and distribution operations.

**Average Trading Volume:** 265,219

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** HK$903.1M

### Related Stocks

- [02502.HK](https://longbridge.com/en/quote/02502.HK.md)

## Related News & Research

- [Westlake Chemical Partners (WLKP) Projected to Post Earnings on Tuesday](https://longbridge.com/en/news/284373416.md)
- [BEACN Announces Financial Results for Year Ended December 31, 2025](https://longbridge.com/en/news/284064586.md)
- [Qingdao Gon Technology Posts Strong Q1 Profit Growth Despite Weaker Cash Flow](https://longbridge.com/en/news/284418347.md)
- [A Look At Robosense Technology (SEHK:2498) Valuation After Mixed Recent Share Price Performance](https://longbridge.com/en/news/284161265.md)
- [Ganfeng Lithium Swings to Strong Profit in First Quarter of 2026](https://longbridge.com/en/news/284606538.md)